Home / Business and Economy / Investor Bets Clash: Stent Maker Soars, Truck Brakes Dip
Investor Bets Clash: Stent Maker Soars, Truck Brakes Dip
3 Nov
Summary
- One investor's heart stent bet is up 35% post-IPO.
- Another's truck brake investment is down 31% from peak.
- Both companies face distinct market and regulatory challenges.
Investor Ashish Kacholia has seen a 35% gain on his pre-IPO investment in Sahajanand Medical Technologies (SMT), a heart-stent maker. The company, which sells globally with nearly 75% revenue from overseas, listed on October 23, 2026, and is now valued at Rs 4,703 crore. However, SMT received a GST summons on its listing day and faces scrutiny over its high inventory days.
Meanwhile, Sunil Singhania's Abakkus Small Cap Fund has continued to acquire shares in ZF Commercial Vehicle Control Systems India, a truck brake manufacturer. The stock is currently trading 31% below its 52-week high, despite the fund's consistent buying. The company benefits from an upcoming October 1, 2027, truck safety rule mandating electronic stability control.
Both SMT and ZF Commercial trade at premium valuations, with SMT at 72x earnings and ZF Commercial at 49x. SMT's first results as a listed company are due on November 5, 2026. ZF Commercial's future trajectory may be significantly influenced by the new truck safety regulations set to take effect on October 1, 2027.
